ArticleJournal of bone oncology2026
Carbon fiber-reinforced peek versus titanium implants for the surgical treatment of spinal metastases: Evaluation of local disease control and quality of life.
Article in Journal of bone oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Carbon fiber-reinforced PEEK (CFRP) spinal instrumentation has emerged as a promising alternative in the oncological setting, allowing for superior postoperative imaging and radiotherapy planning.We aimed to evaluate the survival, local disease control and quality of life in a population of patients with spinal metastases surgically treated with CFRP or titanium implants. Methods: We conducted an observational single-center study on a cohort of 160 patients with vertebral metastases surgically treated from August 2018 to October 2022.Demographic, clinical and surgical data, adverse events and patient-reported outcomes (PROMs) were collected. Results: 129 patients were treated with titanium and 31 patients with CFRP instrumentation. The median survival time of the entire population was 24.3 months, with no statistically significant difference between the two groups ( Conclusion: According to our results, CFRP implants did not confer a statistically significant improvement in survival or local disease control compared with titanium implants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.